8
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: not found
      • Article: not found

      Intradialytic hypotension, blood pressure changes and mortality risk in incident hemodialysis patients

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          <div class="section"> <a class="named-anchor" id="s1"> <!-- named anchor --> </a> <h5 class="section-title" id="d1405161e237">Background</h5> <p id="d1405161e239">Intradialytic hypotension (IDH) occurs frequently in maintenance hemodialysis (HD) patients and may be associated with higher mortality. We hypothesize that nadir intradialytic systolic blood pressure (niSBP) is inversely related to death risk while iSBP change (Δ) and IDH frequency are incrementally associated with all-cause mortality. </p> </div><div class="section"> <a class="named-anchor" id="s2"> <!-- named anchor --> </a> <h5 class="section-title" id="d1405161e242">Methods</h5> <p id="d1405161e244">In a US-based cohort of 112 013 incident HD patients over a 5-year period (2007–11), using niSBP, ΔiSBP (pre-HD SBP minus niSBP) and IDH frequency (proportion of HD treatments with niSBP &lt;90 mmHg) within the first 91 days of HD, we examined mortality-predictability at 1, 2 and 5 years using Cox models and restricted cubic splines adjusted for case-mix, comorbidities and laboratory covariates. </p> </div><div class="section"> <a class="named-anchor" id="s3"> <!-- named anchor --> </a> <h5 class="section-title" id="d1405161e247">Results</h5> <p id="d1405161e249">We observed that niSBP of &lt;90 and ≥140 mmHg had a 5-year mortality hazard ratio (HR) (95% confidence interval) of 1.57 (1.47–1.67) and 1.25 (1.18–1.33), respectively, compared with niSBP 110 to &lt;120 mmHg. ΔiSBP of &lt;15 and ≥50 compared with 21–30 mmHg had mortality HR of 1.31 (1.26–1.37) and 1.32 (1.24–1.39), respectively. Among patients with &gt;40% IDH frequency, we observed a mortality HR of 1.49 (1.42–1.57) compared with 0% IDH frequency in fully adjusted models. These associations were robust at 1 and 2 years of follow-up. </p> </div><div class="section"> <a class="named-anchor" id="s4"> <!-- named anchor --> </a> <h5 class="section-title" id="d1405161e252">Conclusion</h5> <p id="d1405161e254">In conclusion, we observed a U-shaped association between niSBP and ΔiSBP and mortality and a direct linear relationship between IDH frequency and mortality. Our findings lend some prognostic insight of HD blood pressure and hemodynamics, and have the potential to guide blood pressure management strategies among the HD population. </p> </div>

          Related collections

          Most cited references26

          • Record: found
          • Abstract: not found
          • Article: not found

          KDOQI Clinical Practice Guidelines and Clinical Practice Recommendations for Diabetes and Chronic Kidney Disease.

          (2007)
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Hemodialysis-induced cardiac injury: determinants and associated outcomes.

            Hemodialysis (HD)-induced myocardial stunning driven by ischemia is a recognized complication of HD, which can be ameliorated by HD techniques that improve hemodynamics. In nondialysis patients, repeated ischemia leads to chronic reduction in left ventricular (LV) function. HD may initiate and drive the same process. In this study, we examined the prevalence and associations of HD-induced repetitive myocardial injury and long-term effects on LV function and patient outcomes. Seventy prevalent HD patients were assessed for evidence of subclinical myocardial injury at baseline using serial echocardiography and followed up after 12 mo. Intradialytic blood pressure, hematologic and biochemical samples, and patient demographics were also collected at both time points. Sixty-four percent of patients had significant myocardial stunning during HD. Age, ultrafiltration volumes, intradialytic hypotension, and cardiac troponin-T (cTnT) levels were independent determinants associated with its presence. Myocardial stunning was associated with increased relative mortality at 12 mo (P = 0.019). Cox regression analysis showed increased hazard of death in patients with myocardial stunning and elevated cTnT than in patients with elevated cTnT alone (P < 0.02). Patients with myocardial stunning who survived 12 mo had significantly lower LV ejection fractions at rest and on HD (P < 0.001). HD-induced myocardial stunning is common, and may contribute to the development of heart failure and increased mortality in HD patients. Enhanced understanding of dialysis-induced cardiac injury may provide novel therapeutic targets to reduce currently excessive rates of cardiovascular morbidity and mortality.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Hemodialysis-associated hypotension as an independent risk factor for two-year mortality in hemodialysis patients.

              The relationship between blood pressure (BP) and mortality in hemodialysis patients has remained controversial. Some studies suggested that a lower pre- or postdialysis BP was associated with excess mortality, while others showed poorer outcome in patients with uncontrolled hypertension. We conducted a multicenter prospective cohort study to evaluate the impact of hemodialysis-associated hypotension on mortality. We recruited 1244 patients (685 males; mean age, 60 +/- 13 years) who underwent hemodialysis in 28 units during the two-year study period beginning in December 1999. Pre-, intra-, and postdialysis BP, and BP upon standing soon after hemodialysis, were measured in all patients at entry. Logistic regression analysis was used to assess the effect on mortality of pre-, intra-, and postdialysis BP, a fall in BP during hemodialysis, and a fall in BP upon standing soon after hemodialysis. During the study period, 149 patients died. Logistic models identified the lowest intradialysis systolic blood pressure (SBP) and degree of fall in SBP upon standing soon after hemodialysis as significant factors affecting mortality, but not pre- or postdialysis SBP and diastolic BP. The adjusted odds ratio for death was 0.79 (95% CI 0.64-0.98) when the lowest intradialysis SBP was analyzed in increments of 20 mm Hg, and was 0.82 (95% CI 0.67-0.98) when the fall in SBP upon standing soon after hemodialysis was analyzed in increments of 10 mm Hg. These results suggest that intradialysis hypotension and orthostatic hypotension after hemodialysis are significant and independent factors affecting mortality in hemodialysis patients.
                Bookmark

                Author and article information

                Journal
                Nephrology Dialysis Transplantation
                Oxford University Press (OUP)
                0931-0509
                1460-2385
                January 2018
                January 01 2018
                April 21 2017
                January 2018
                January 01 2018
                April 21 2017
                : 33
                : 1
                : 149-159
                Affiliations
                [1 ]Harold Simmons Center for Kidney Disease Research and Epidemiology, University of California Irvine, School of Medicine, Orange, CA, USA
                [2 ]Department of Medicine, University of California, Irvine, School of Medicine, Orange, CA, USA
                [3 ]Quintiles Therapeutic Science and Strategy Unit, San Diego, California
                [4 ]Division of Nephrology, University of Tennessee Health Science Center, Memphis, TN, USA
                [5 ]Nephrology Section, Memphis VA Medical Center, Memphis, TN, USA
                [6 ]Division of Nephrology and Hypertension, Kaiser Permanente Medical Center, Los Angeles, CA, USA
                [7 ]Fielding School of Public Health at UCLA, Los Angeles, CA, USA
                [8 ]Los Angeles Biomedical Research Institute at Harbor-UCLA, Torrance, CA, USA
                Article
                10.1093/ndt/gfx037
                5837776
                28444336
                d7383e44-dc59-42c3-9a60-bbbdaa4d0f9f
                © 2017
                History

                Comments

                Comment on this article